Top Markets
Coin of the day
Phoenix Life Sciences International Limited Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited

PLSI
Rank in Stocks #42848
Phoenix Life Sciences International Limited operates as a global healthcare... Phoenix Life Sciences International Limited operates as a global healthcare solutions provider, conducting business in the United States and internationally. The company primarily concentrates on pioneering research, developing integrated programs, and producing goods aimed at the prevention and treatment of a broad spectrum of conditions. These include diabetes, pain, and various cancers, as well as psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. Its diverse product line encompasses oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. Established in 2009, the company was initially known as Stem Bioscience, Inc., before officially adopting the name Phoenix Life Sciences International Limited in May 2018. Its corporate headquarters are located in Las Vegas, Nevada.
Share Price
$0.0001
Last synced: 2023-09-25
Market Cap
$2.82
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Phoenix Life Sciences International Limited (PLSI)

Category

P/B ratio for Phoenix Life Sciences International Limited (PLSI)
P/B ratio as of 2026 TTM: 0
According to Phoenix Life Sciences International Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Phoenix Life Sciences International Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors